1 / 9

EpiCast: Global Atrial Fibrillation Market Epidemiology

Big Market Research, EpiCast Report: Atrial Fibrillation Epidemiology Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, to 2023. Browse complete report & TOC @ http://www.bigmarketresearch.com/epicast-report-atrial-fibrillation-epidemiology-forecast-to-2023-market Atrial fibrillation (AF) is a disorder of the heart’s electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide. According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world''s population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population, especially the elderly population. Researcher epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. Researcher epidemiologists attribute the growth in the diagnosed prevalent cases of AF in the 8MM to the changing population demographics in the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these markets.

carlahindss
Download Presentation

EpiCast: Global Atrial Fibrillation Market Epidemiology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023 www.bigmarketresearch.com

  2. Report Description Summary Atrial fibrillation (AF) is a disorder of the heart’s electrical system. The condition is characterized by an irregular heart rhythm that is either too fast or too slow. During AF, the two upper chambers of the heart (atria) beat out of coordination with the two lower chambers (ventricles) due to disorganized electrical signals, resulting in poor blood supply to the lungs and the rest of the body. The symptoms of AF typically include heart palpitations, irregular and fast heartbeat, chest discomfort, shortness of breath, dizziness, and weakness. However, individuals with AF may be asymptomatic and not even know that they have the condition until it is identified through an electrocardiogram (EKG or ECG) test. Browse complete report @ http://www.bigmarketresearch.com/epicast-report-atrial-fibrillation-epidemiology-forecast-to-2023-market

  3. Report Description AF is one of the most common cardiovascular diseases among the elderly, worldwide. Although AF affects people of all ages, the condition is rare in individuals younger than 40 years of age. The risk for AF increases rapidly with age and is more common in men than women. Globally, the prevalence of AF varies widely, depending on the country and the study, ranging from 0.1-1.6% in Asia (0.1% in India, 1.6% in Japan), 0.95-3.9% in North America (0.95% in the US, 3.9% in Canada), 1.28-2.1% in Europe (1.28% in the UK, 2.1% in Germany), and 4.0% in Australia. GlobalData epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. Feel free to enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/190797

  4. Report Description GlobalData’s epidemiological forecast for the diagnosed prevalent cases of AF in the 8MM is supported by epidemiologic data from country-specific studies that are nationally representative of the entire population in these markets. This analysis included the most recently published nationally-representative studies in the 8MM, which provided the diagnosed prevalence of AF using uniform diagnostic criteria based on EKG tests, which facilitated a meaningful comparison of the forecast for the diagnosed prevalent cases of AF in the 8MM. Need Discount? Request here @ http://www.bigmarketresearch.com/purchase-enquiry/190797

  5. Report Description Scope The Atrial Fibrillation (AF) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for AF in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of AF segmented by sex, age (in five-year age groups, beginning at 40 years and ending at =85 years), and clinical subtypes (paroxysmal, persistent, and permanent AF) in these markets. The AF epidemiology report is written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

  6. Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 2.3 Upcoming Related Reports 3 Epidemiology 3.1 Disease Background 3.2 Risk Factors and Comorbidities 3.3 Global Trends 3.4 Forecast Methodology 3.4.1 Sources Used 3.4.2 Forecast Assumptions and Methods 3.4.3 Sources Not Used

  7. Table of Contents 3.5 Epidemiological Forecast for Atrial Fibrillation (2013-2023) 3.5.1 Diagnosed Prevalent Cases of Atrial Fibrillation 3.5.2 Age-Specific Diagnosed Prevalent Cases of Atrial Fibrillation 3.5.3 Sex-Specific Diagnosed Prevalent Cases of Atrial Fibrillation 3.5.4 Age-Standardized Diagnosed Prevalence of Atrial Fibrillation 3.5.5 Diagnosed Prevalent Cases of Atrial Fibrillation by Clinical Subtypes 3.6 Discussion 3.6.1 Epidemiological Forecast Insight 3.6.2 Limitations of the Analysis 3.6.3 Strengths of the Analysis 4 Appendix 4.1 Bibliography 4.2 About the Authors 4.2.1 Epidemiologists 4.2.2 Reviewers 4.2.3 Global Director of Therapy Analysis and Epidemiology

  8. Report Description • Reasons to buy • Develop business strategies by understanding the trends shaping and driving the global AF market. • Quantify patient populations in the global AF market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for AF therapeutics in each of the markets covered.

  9. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/epicast-report-atrial-fibrillation-epidemiology-forecast-to-2023-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related